Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A,
Wieberdink RG, Breteler MM, Witteman JC, Van Den Meiracker AH (2010).
Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and
cerebrovascular risk prediction in the population: the Rotterdam study.
Hypertension 55, 785-91.
Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A (2004).
Decreasing one-year mortality and hospitalization rates for heart failure in
Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.
Eur Heart J 25, 300-7.
Schellenbaum GD, Rea TD, Heckbert SR, Smith NL, Lumley T, Roger VL, Kitzman
DW, Taylor HA, Levy D, Psaty BM (2004). Survival associated with two sets
of diagnostic criteria for congestive heart failure. Am J Epidemiol 160, 628-
35.
Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F (2000).
Continuous relation between left ventricular mass and cardiovascular risk in
essential hypertension. Hypertension 35, 580-6.
Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA,
Narula J, Shor ES, Young JB, Hong Y (2008). Prevention of heart failure: a
scientific statement from the American Heart Association Councils on
Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing,
and High Blood Pressure Research; Quality of Care and Outcomes Research
Interdisciplinary Working Group; and Functional Genomics and Translational
Biology Interdisciplinary Working Group. Circulation 117, 2544-65.
Schuit AJ, Wendel-Vos GCW, Verschuren WMM, Ronckers ET, Ament A, Van
Assema P, Van Ree J, Ruland EC (2006). Effect of 5-year community
intervention Hartslag Limburg on cardiovascular risk factors. Am J Prev Med
2006;30:237-42.
Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH,
Riegger GA (1994). Association between a deletion polymorphism of the
angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl
J Med 330, 1634-8.
Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR,
Redfield MM (1998). Congestive heart failure in the community: a study of all
incident cases in Olmsted County, Minnesota, in 1991. Circulation 98, 2282-
9.
Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR,
Redfield MM (1999). Congestive heart failure in the community: trends in
incidence and survival in a 10-year period. Arch Intern Med 159, 29-34.
Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A (2009).
Survival trends in men and women with heart failure of ischaemic and nonischaemic
origin: data for the period 1987-2003 from the Swedish Hospital
Discharge Registry. Eur Heart J 30, 671-8.
Shafazand M, Rosengren A, Lappas G, Swedberg K, Schaufelberger M (2011).
Decreasing trends in the incidence of heart failure after acute myocardial
infarction from 1993-2004: a study of 175,216 patients with a first acute
myocardial infarction in Sweden. Eur J Heart Fail 13, 135-41.
Shah AS, Khoury PR, Dolan LM, Ippisch HM, Urbina EM, Daniels SR, Kimball TR
(2011). The effects of obesity and type 2 diabetes mellitus on cardiac
structure and function in adolescents and young adults. Diabetologia 54:
722-30.
Simpson HJ, Gandy SJ, Houston JG, Rajendra NS, Davies JI, Struthers AD
(2010). Left ventricular hypertrophy: reduction of blood pressure already in
the normal range further regresses left ventricular mass. Heart 96, 148-52.
Pagina 111 van 122